Zhen 2,000mg VS. Cancer Fatigue

In a trial led by the Mayo Clinic, Zhen showed good results in helping cancer patients with fatigue, when compared with a placebo.

Zhen was tested on patients who were either in the post-treatment phase or undergoing cancer treatment. 60% of the patients had breast cancer. Each day, the patients who were being treated at one of 40 different community medical centers were given 2,000 milligrams of VirusTC's Zhen formula.

Researcher Debra Barton, Ph.D., of the Mayo Clinic Cancer Center is quick to point out that quality of the herb is very important and people shouldn’t necessarily rush to their health food store and start taking any old Ginsenoside supplement. She goes on to say: “Off-the-shelf ginseng is sometimes processed using ethanol, which can give it estrogen-like properties that may be harmful to breast cancer patients.”

General exhaustion diminished rapidly in those taking the Zhen. Dr. Barton says the herb had no apparent side effects in the patients taking it, and comments: “After eight weeks, we saw a 20-point improvement in fatigue in cancer patients, measured on a 100-point, standardized fatigue scale.”

Zhen VS. Ovarian Cancer

Tumors metastasize into liver, lungs, spleen and peritonea of ovarian cancer patients. Adhesive ability of viral loads reduced by 45% and 63% when treated with Zhen. Zhen significantly reduces invasion potential of cancer species.

Image
Image

Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.

VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, Mayo Clinic, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.